The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer

SIMPLE SUMMARY: Chemotherapy and chemoradiotherapy are only effective in 25% to 30% of patients with oesophageal cancer. Being able to predict which patients will respond to chemotherapy and chemoradiotherapy before they receive this treatment will prevent patients undergoing unnecessary procedures...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Cameron C. J., Lloyd, Megan, Alyacoubi, Said, Rahman, Saqib, Pickering, Oliver, Underwood, Tim, Breininger, Stella P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909542/
https://www.ncbi.nlm.nih.gov/pubmed/35267476
http://dx.doi.org/10.3390/cancers14051171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909542/
https://www.ncbi.nlm.nih.gov/pubmed/35267476
http://dx.doi.org/10.3390/cancers14051171

Ejemplares similares